Advertisement

Archives of Osteoporosis

, 14:20 | Cite as

Osteoporosis strategic plan for the Middle East and North Africa region

  • Patricia Khashayar
  • Eghbal Taheri
  • Gemma Adib
  • Leith Zakraoui
  • Bagher LarijaniEmail author
Original Article

Abstract

Summary

The first step to achieve a world without fragility fractures is to devise a strategic plan to improve research and planning, and assisting member states to acquire the required financial, technical, and other resources. This article aims to outline the first strategic plan devised for the Middle East and North Africa region proposed by the International Osteoporosis Foundation’s (IOF) Middle East and North Africa (MENA) Regional Advisory Council (RAC).

Purpose

Osteoporosis is no exception in this rising tide of non-communicable diseases, not only sharing common risk factors but also contributing substantially to a heavy social and economic burden on society. During the past decade and after the establishment of the International Osteoporosis Foundation (IOF), a goal-directed movement has started to achieve a world without fragility fractures. In order to achieve this goal, regional councils were formed to maximize the effectiveness of national osteoporosis societies in raising awareness of effective prevention, diagnosis, and treatment strategies.

Methods and results

The first step to achieve this goal is to devise a strategic plan to improve the research and planning, assisting all member states to acquire the financial, technical, and other resources needed in order to achieve a world-class program in the fight against osteoporosis.

Conclusion

This article therefore aims to outline the first strategic plan devised by the IOF’s MENA RAC for the Middle East and North Africa region.

Keywords

Osteoporosis Middle East and North Africa region Fragility fracture 

Notes

Compliance with ethical standards

Conflicts of interest

None.

References

  1. 1.
    Bloom, D.E., Cafiero, E.T., Jané-Llopis, E., Abrahams-Gessel, S., Bloom, L.R., Fathima, S., Feigl, A.B., Gaziano, T., Mowafi, M., Pandya, A., Prettner, K., Rosenberg, L., Seligman, B., Stein, A., & Weinstein, C. (2011). The Global Economic Burden of Non-communicable Diseases. Geneva: World Economic ForumGoogle Scholar
  2. 2.
    (2011) Global status report on noncommunicable diseases 2010. Geneva: World Health OrganizationGoogle Scholar
  3. 3.
    Sunil Kumar KH, Bhaskar P (2012) Osteoporosis - an emerging disease of the 21(st) century, part 1: an overview. J Family Med Prim Care 1:66–68.  https://doi.org/10.4103/2249-4863.94457 CrossRefPubMedPubMedCentralGoogle Scholar
  4. 4.
    Ghada El-Hajj Fuleihan, Gemma Adib, Nauroy L. (2011) The Middle East and Africa Regional Audit: Epidemiology, costs & burden of osteoporosis in 2011. International Osteoporosis FoundationGoogle Scholar
  5. 5.
    Maalouf G, Gannage-Yared MH, Ezzedine J et al (2007) Middle East and North Africa consensus on osteoporosis. J Musculoskelet Neuronal Interact 7:131–143PubMedGoogle Scholar
  6. 6.
    El-Heis MA, Al-Kamil EA, Kheirallah KA, et al (2013) Factors associated with osteoporosis among a sample of Jordanian women referred for investigation for osteoporosis لدهين العظام ختلخل الستقصاء َّ إحالتهن ت َّ مت الاليت األردنيات النساء من عينة لدى العظام لتخلخل املرافقة العواملGoogle Scholar
  7. 7.
    Khashayar P, Reza H, Meybodi A et al (2016) Vitamin D status and its relationship with bone mineral density in a healthy Iranian population Correlação entre os níveis de vitamina D e densidade mineral óssea em uma população iraniana saudável. Rev Bras Ortop 51:454–458.  https://doi.org/10.1016/j.rboe.2015.09.011 CrossRefPubMedPubMedCentralGoogle Scholar
  8. 8.
    Chakhtoura M, Rahme M, Chamoun N, El-Hajj Fuleihan G (2018) Vitamin D in the Middle East and North Africa. Bone Reports 8:135–146.  https://doi.org/10.1016/J.BONR.2018.03.004 CrossRefPubMedPubMedCentralGoogle Scholar
  9. 9.
    El-Rassi R, Baliki G, El G, Fulheihan H (2011) Vitamin D status in Middle East and Africa. International Osteoporosis FoundationGoogle Scholar
  10. 10.
    Lewiecki EM, Watts NB (2009) New guidelines for the prevention and treatment of osteoporosis New NOF Guidelines. South Med J.; 102(2):175-9Google Scholar
  11. 11.
    Nevin Hammam TAG (2018) Epidemiology and awareness of osteoporosis: a viewpoint from the Middle East and North Africa. Int J Clin Rheumtol 13.  https://doi.org/10.4172/1758-4272.1000177
  12. 12.
    Matthews HL, Laya M, DeWitt DE (2006) Rural women and osteoporosis: awareness and educational needs. J Rural Health 22:279–283.  https://doi.org/10.1111/j.1748-0361.2006.00047.x CrossRefPubMedGoogle Scholar
  13. 13.
    Kutsal YG, Atalay A, Arslan Ş, Başaran A, Cantürk F, Cindaş A, Eryavuz M, İrdesel J, Karadavut Kİ, Kirazlı Y, Sindel D, Şenel K, Güler-Uysal F, Yıldırım K (2005) Awareness of osteoporotic patients. Osteoporos Int 16:128–133.  https://doi.org/10.1007/s00198-004-1678-2 CrossRefPubMedGoogle Scholar
  14. 14.
    Sweileh WM, Al-Jabi SW, Zyoud SH et al (2014) Osteoporosis is a neglected health priority in Arab world: a comparative bibliometric analysis. Springerplus 3(427).  https://doi.org/10.1186/2193-1801-3-427
  15. 15.
    Murray CJL, Vos T, Lozano R, Naghavi M, Flaxman AD, Michaud C, Ezzati M, Shibuya K, Salomon JA, Abdalla S, Aboyans V, Abraham J, Ackerman I, Aggarwal R, Ahn SY, Ali MK, AlMazroa MA, Alvarado M, Anderson HR, Anderson LM, Andrews KG, Atkinson C, Baddour LM, Bahalim AN, Barker-Collo S, Barrero LH, Bartels DH, Basáñez MG, Baxter A, Bell ML, Benjamin EJ, Bennett D, Bernabé E, Bhalla K, Bhandari B, Bikbov B, Abdulhak AB, Birbeck G, Black JA, Blencowe H, Blore JD, Blyth F, Bolliger I, Bonaventure A, Boufous S, Bourne R, Boussinesq M, Braithwaite T, Brayne C, Bridgett L, Brooker S, Brooks P, Brugha TS, Bryan-Hancock C, Bucello C, Buchbinder R, Buckle G, Budke CM, Burch M, Burney P, Burstein R, Calabria B, Campbell B, Canter CE, Carabin H, Carapetis J, Carmona L, Cella C, Charlson F, Chen H, Cheng ATA, Chou D, Chugh SS, Coffeng LE, Colan SD, Colquhoun S, Colson KE, Condon J, Connor MD, Cooper LT, Corriere M, Cortinovis M, de Vaccaro KC, Couser W, Cowie BC, Criqui MH, Cross M, Dabhadkar KC, Dahiya M, Dahodwala N, Damsere-Derry J, Danaei G, Davis A, Leo DD, Degenhardt L, Dellavalle R, Delossantos A, Denenberg J, Derrett S, Des Jarlais DC, Dharmaratne SD, Dherani M, Diaz-Torne C, Dolk H, Dorsey ER, Driscoll T, Duber H, Ebel B, Edmond K, Elbaz A, Ali SE, Erskine H, Erwin PJ, Espindola P, Ewoigbokhan SE, Farzadfar F, Feigin V, Felson DT, Ferrari A, Ferri CP, Fèvre EM, Finucane MM, Flaxman S, Flood L, Foreman K, Forouzanfar MH, Fowkes FGR, Fransen M, Freeman MK, Gabbe BJ, Gabriel SE, Gakidou E, Ganatra HA, Garcia B, Gaspari F, Gillum RF, Gmel G, Gonzalez-Medina D, Gosselin R, Grainger R, Grant B, Groeger J, Guillemin F, Gunnell D, Gupta R, Haagsma J, Hagan H, Halasa YA, Hall W, Haring D, Haro JM, Harrison JE, Havmoeller R, Hay RJ, Higashi H, Hill C, Hoen B, Hoffman H, Hotez PJ, Hoy D, Huang JJ, Ibeanusi SE, Jacobsen KH, James SL, Jarvis D, Jasrasaria R, Jayaraman S, Johns N, Jonas JB, Karthikeyan G, Kassebaum N, Kawakami N, Keren A, Khoo JP, King CH, Knowlton LM, Kobusingye O, Koranteng A, Krishnamurthi R, Laden F, Lalloo R, Laslett LL, Lathlean T, Leasher JL, Lee YY, Leigh J, Levinson D, Lim SS, Limb E, Lin JK, Lipnick M, Lipshultz SE, Liu W, Loane M, Ohno SL, Lyons R, Mabweijano J, MacIntyre MF, Malekzadeh R, Mallinger L, Manivannan S, Marcenes W, March L, Margolis DJ, Marks GB, Marks R, Matsumori A, Matzopoulos R, Mayosi BM, McAnulty JH, McDermott MM, McGill N, McGrath J, Medina-Mora ME, Meltzer M, Memish ZA, Mensah GA, Merriman TR, Meyer AC, Miglioli V, Miller M, Miller TR, Mitchell PB, Mock C, Mocumbi AO, Moffitt TE, Mokdad AA, Monasta L, Montico M, Moradi-Lakeh M, Moran A, Morawska L, Mori R, Murdoch ME, Mwaniki MK, Naidoo K, Nair MN, Naldi L, Narayan KMV, Nelson PK, Nelson RG, Nevitt MC, Newton CR, Nolte S, Norman P, Norman R, O'Donnell M, O’Hanlon S, Olives C, Omer SB, Ortblad K, Osborne R, Ozgediz D, Page A, Pahari B, Pandian JD, Rivero AP, Patten SB, Pearce N, Padilla RP, Perez-Ruiz F, Perico N, Pesudovs K, Phillips D, Phillips MR, Pierce K, Pion S, Polanczyk GV, Polinder S, Pope CA III, Popova S, Porrini E, Pourmalek F, Prince M, Pullan RL, Ramaiah KD, Ranganathan D, Razavi H, Regan M, Rehm JT, Rein DB, Remuzzi G, Richardson K, Rivara FP, Roberts T, Robinson C, de Leòn FR, Ronfani L, Room R, Rosenfeld LC, Rushton L, Sacco RL, Saha S, Sampson U, Sanchez-Riera L, Sanman E, Schwebel DC, Scott JG, Segui-Gomez M, Shahraz S, Shepard DS, Shin H, Shivakoti R, Silberberg D, Singh D, Singh GM, Singh JA, Singleton J, Sleet DA, Sliwa K, Smith E, Smith JL, Stapelberg NJC, Steer A, Steiner T, Stolk WA, Stovner LJ, Sudfeld C, Syed S, Tamburlini G, Tavakkoli M, Taylor HR, Taylor JA, Taylor WJ, Thomas B, Thomson WM, Thurston GD, Tleyjeh IM, Tonelli M, Towbin JA, Truelsen T, Tsilimbaris MK, Ubeda C, Undurraga EA, van der Werf MJ, van Os J, Vavilala MS, Venketasubramanian N, Wang M, Wang W, Watt K, Weatherall DJ, Weinstock MA, Weintraub R, Weisskopf MG, Weissman MM, White RA, Whiteford H, Wiebe N, Wiersma ST, Wilkinson JD, Williams HC, Williams SRM, Witt E, Wolfe F, Woolf AD, Wulf S, Yeh PH, Zaidi AKM, Zheng ZJ, Zonies D, Lopez AD (2012) Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 380:2197–2223.  https://doi.org/10.1016/S0140-6736(12)61689-4 CrossRefGoogle Scholar
  16. 16.
    Odén A, McCloskey EV, Kanis JA, Harvey NC, Johansson H (2015) Burden of high fracture probability worldwide: secular increases 2010--2040. Osteoporos Int 26:2243–2248.  https://doi.org/10.1007/s00198-015-3154-6 CrossRefPubMedGoogle Scholar
  17. 17.
    Vijayakumar R, Büsselberg D (2016) Osteoporosis: an under-recognized public health problem local and global risk factors and its regional and worldwide prevalence. J Local Glob Health Sci 2016:2.  https://doi.org/10.5339/jlghs.2016.2 CrossRefGoogle Scholar
  18. 18.
    Peykari N, Hashemi H, Dinarvand R, Haji-Aghajani M, Malekzadeh R, Sadrolsadat A, Sayyari AA, Asadi-lari M, Delavari A, Farzadfar F, Haghdoost A, Heshmat R, Jamshidi H, Kalantari N, Koosha A, Takian A, Larijani B (2017) National action plan for non-communicable diseases prevention and control in Iran; a response to emerging epidemic. J Diabetes Metab Disord 16(3):3.  https://doi.org/10.1186/s40200-017-0288-4 CrossRefPubMedPubMedCentralGoogle Scholar
  19. 19.
    Bassil D, Rahme M, Hoteit M, Fuleihan GE-H (2013) Hypovitaminosis D in the Middle East and North Africa: prevalence, risk factors and impact on outcomes. Dermatoendocrinol 5:274–298.  https://doi.org/10.4161/derm.25111 CrossRefPubMedPubMedCentralGoogle Scholar
  20. 20.
    Maalouf G, Bachour F, Hlais S, Maalouf NM, Yazbeck P, Yaghi Y, Yaghi K, el Hage R, Issa M (2013) Epidemiology of hip fractures in Lebanon: a nationwide survey. Orthop Traumatol Surg Res 99:675–680.  https://doi.org/10.1016/j.otsr.2013.04.009 CrossRefPubMedGoogle Scholar
  21. 21.
    Azizieh F (2017) Fractures in Kuwait: incidence and distribution. Risk Manag Healthc Policy Volume 10:117–125.  https://doi.org/10.2147/RMHP.S136844 CrossRefGoogle Scholar
  22. 22.
    Irani AD, Poorolajal J, Khalilian A et al (2013) Prevalence of osteoporosis in Iran: a meta-analysis. J Res Med Sci 18(9):759–766PubMedPubMedCentralGoogle Scholar
  23. 23.
    Ahmadi-Abhari S, Moayyeri A, Abolhassani F (2007) Burden of hip fracture in Iran. Calcif Tissue Int 80:147–153CrossRefGoogle Scholar
  24. 24.
    Abolhassani F, Mohammadi M, Soltani A (2004) Burden of osteoporosis in Iran. Iran J Publ Heal Suppl; 33:18–28Google Scholar
  25. 25.
    Alghamdi MA, Mohammed AGA (2018) Knowledge and awareness of osteoporosis among Saudi physicians and nurses: a cross-sectional study. Open Access Maced J Med Sci 6:913–916.  https://doi.org/10.3889/oamjms.2018.177 CrossRefPubMedPubMedCentralGoogle Scholar
  26. 26.
    Zakai G, Zakai H, Medicine F, Arabia S (2015) Awareness about osteoporosis among university students in Jeddah , Saudi Arabia. J Adv Lab Res Biol; 6(2): 43-47Google Scholar
  27. 27.
    Elsabagh HM, Aldeib AF, Atlam SA, Saied SM (2015) Osteoporosis knowledge and health beliefs among employees of Tanta University. Am J Res Com. 12: 62-77Google Scholar
  28. 28.
    El-Tawab SS, Saba EKA, Elweshahi HMT, Ashry MH (2016) Knowledge of osteoporosis among women in Alexandria (Egypt): a community based survey. Egypt Rheumatol 38:225–231.  https://doi.org/10.1016/J.EJR.2015.08.001 CrossRefGoogle Scholar
  29. 29.
    Jalili Z, Nakhaee N, Askari R, Sharifi V (2007) Knowledge, attitude and preventive practice of women concerning osteoporosis. Iran J Public Health 36(2):19–24Google Scholar
  30. 30.
    Khashayar P, Qorbani M, Keshtkar A, Khashayar P, Ziaee A, Larijani B (2017) Awareness of osteoporosis among female head of household: an Iranian experience. Arch Osteoporos 12:36.  https://doi.org/10.1007/s11657-017-0330-7 CrossRefPubMedGoogle Scholar
  31. 31.
    Mahdaviazad H, Keshtkar V, Emami MJ (2018) Osteoporosis guideline awareness among Iranian family physicians: results of a knowledge, attitudes, and practices survey. Prim Health Care Res Dev 19:485–491.  https://doi.org/10.1017/S1463423618000014 CrossRefPubMedGoogle Scholar
  32. 32.
    Johansen A, Golding D, Brent L, Close J, Gjertsen JE, Holt G, Hommel A, Pedersen AB, Röck ND, Thorngren KG (2017) Using national hip fracture registries and audit databases to develop an international perspective. Injury 48:2174–2179.  https://doi.org/10.1016/J.INJURY.2017.08.001 CrossRefPubMedGoogle Scholar
  33. 33.
    Tian M, Gong X, Rath S, Wei J, Yan LL, Lamb SE, Lindley RI, Sherrington C, Willett K, Norton R (2016) Management of hip fractures in older people in Beijing: a retrospective audit and comparison with evidence-based guidelines and practice in the UK. Osteoporos Int 27:677–681.  https://doi.org/10.1007/s00198-015-3261-4 CrossRefPubMedGoogle Scholar
  34. 34.
    El-Hajj Fuleihan G (2010) Vitamin D deficiency in the Middle East and its health consequences. In: Vitamin D. Humana Press, Totowa, pp 469–494CrossRefGoogle Scholar
  35. 35.
    Nguyen TV, Center JR, Eisman JA (2004) Osteoporosis: underrated, underdiagnosed and undertreated. Med J Aust 180:S18–S22PubMedGoogle Scholar
  36. 36.
    Miller PD (2016) Underdiagnoses and undertreatment of osteoporosis: the battle to be won. J Clin Endocrinol Metab 101:852–859.  https://doi.org/10.1210/jc.2015-3156 CrossRefPubMedGoogle Scholar
  37. 37.
    Westesson P-L, Lee RK, Ketkar MA, Lin Edward P (2002) Underdiagnosis and undertreatment of osteoporosis. Lancet 360:1891CrossRefGoogle Scholar
  38. 38.
    Mitchell PJ (2013) Best practices in secondary fracture prevention: fracture liaison services. Curr Osteoporos Rep 11:52–60.  https://doi.org/10.1007/s11914-012-0130-3 CrossRefPubMedGoogle Scholar

Copyright information

© International Osteoporosis Foundation and National Osteoporosis Foundation 2019

Authors and Affiliations

  • Patricia Khashayar
    • 1
    • 2
  • Eghbal Taheri
    • 3
  • Gemma Adib
    • 4
  • Leith Zakraoui
    • 5
  • Bagher Larijani
    • 3
    Email author
  1. 1.Center for Microsystems Technologyimec and Ghent UniversityGhentBelgium
  2. 2.Osteoporosis Research Center, Endocrinology and Metabolism Clinical Sciences InstituteTehran University of Medical SciencesTehranIran
  3. 3.Endocrinology and Metabolism Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Shariati HospitalTehran University of Medical SciencesTehranIran
  4. 4.Syrian Council of OsteoporosisDamascusSyria
  5. 5.Rheumatology DepartmentMongi Slim HospitalLa MarsaTunisia

Personalised recommendations